J&J Wins FDA Nod for Erleada, the First Drug for Nonmetastatic Prostate Cancer Post author:Sam Post published:February 14, 2018 Post category:BioPharma Janssen got a little love from the FDA on Wednesday. Source: BioSpace You Might Also Like Novartis Buys Access to Spark's Landmark Gene Therapy Drug With $170M Deal January 24, 2018 Teva Board Members Take 50% Pay Cut January 10, 2018 Semler Scientific Reports Fourth Quarter And Annual 2016 Financial Results March 9, 2017
